Related Experiment Video
Updated: May 20, 2026
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Diagnostic issues in pediatric drug allergy
Jean-Christoph Caubet1, Philippe A Eigenmann
1University Hospitals of Geneva and Medical School of The University of Geneva, Department of Child and Adolescent, Geneva, Switzerland. Jean-Christoph.Caubet@hcuge.ch
Current Opinion in Allergy and Clinical Immunology
|July 7, 2012
Summary
Accurate diagnosis of pediatric drug allergies is crucial. A comprehensive allergy work-up, including drug provocation tests, helps avoid misdiagnosis and unnecessary restrictions for antibiotics, NSAIDs, and vaccines.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Pharmacology
- Immunology
Background:
- Drug allergies are common in pediatric practice, yet understanding of their mechanisms remains limited.
- This knowledge gap hinders accurate diagnosis of allergic drug reactions.
- Commonly implicated drugs include antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and vaccines.
Purpose of the Study:
- To review recent literature on diagnosing drug allergies in children.
- Focus on antibiotics, NSAIDs, and vaccines.
- To improve diagnostic accuracy and patient outcomes.
Main Methods:
- Systematic review of recent literature.
- Emphasis on diagnostic approaches for specific drug classes.
- Evaluation of diagnostic tools, including drug provocation tests.
Main Results:
- Systematic approaches can reduce inappropriate 'drug allergic' labeling.
- Complete allergy work-up is essential upon suspicion.
- Drug provocation tests are the gold standard, especially for antibiotic-associated rashes.
- New diagnostic tools show promising results.
Conclusions:
- Accurate drug allergy diagnosis prevents severe reactions and healthcare costs.
- Avoids unnecessary drug restrictions, mitigating antimicrobial resistance.
- Highlights the importance of proper diagnostic evaluation in pediatric drug allergy.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...